Invitae Inks $15M Loan Agreement | GenomeWeb

NEW YORK(GenomeWeb) – Invitae has entered into a $15 million loan agreement with Silicon Valley Bank to purchase equipment, the firm said in a document filed with the US Securities and Exchange Commission on Wednesday. 

Invitae drew down an initial tranche of $2.5 million and can draw down additional tranches of up to $2 million each. Under the terms of the deal, the firm may request additional tranches for the purchase of equipment through December 31, 2016 subject to certain restrictions, it said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

Sponsored by
Agilent Technologies

In this online seminar, speakers from the Center for Personalized Diagnostics at Penn Medicine will discuss the design and technical validation of a custom next-generation sequencing panel to detect mutations in a wide array of tumor types.